369 related articles for article (PubMed ID: 17392437)
1. Phenotypic characterization of clonal and nonclonal Pseudomonas aeruginosa strains isolated from lungs of adults with cystic fibrosis.
Tingpej P; Smith L; Rose B; Zhu H; Conibear T; Al Nassafi K; Manos J; Elkins M; Bye P; Willcox M; Bell S; Wainwright C; Harbour C
J Clin Microbiol; 2007 Jun; 45(6):1697-704. PubMed ID: 17392437
[TBL] [Abstract][Full Text] [Related]
2. Type 3 secretion system effector genotype and secretion phenotype of longitudinally collected Pseudomonas aeruginosa isolates from young children diagnosed with cystic fibrosis following newborn screening.
Hu H; Harmer C; Anuj S; Wainwright CE; Manos J; Cheney J; Harbour C; Zablotska I; Turnbull L; Whitchurch CB; Grimwood K; Rose B;
Clin Microbiol Infect; 2013 Mar; 19(3):266-72. PubMed ID: 22329595
[TBL] [Abstract][Full Text] [Related]
3. Characterization of N-butanoyl-L-homoserine lactone (C4-HSL) deficient clinical isolates of Pseudomonas aeruginosa.
Boşgelmez-Tinaz G; Ulusoy S
Microb Pathog; 2008 Jan; 44(1):13-9. PubMed ID: 17689222
[TBL] [Abstract][Full Text] [Related]
4. Poor clinical outcomes associated with a multi-drug resistant clonal strain of Pseudomonas aeruginosa in the Tasmanian cystic fibrosis population.
Bradbury R; Champion A; Reid DW
Respirology; 2008 Nov; 13(6):886-92. PubMed ID: 18811887
[TBL] [Abstract][Full Text] [Related]
5. Clinical profile of adult cystic fibrosis patients with frequent epidemic clones of Pseudomonas aeruginosa.
Tingpej P; Elkins M; Rose B; Hu H; Moriarty C; Manos J; Barras B; Bye P; Harbour C
Respirology; 2010 Aug; 15(6):923-9. PubMed ID: 20573059
[TBL] [Abstract][Full Text] [Related]
6. Pseudomonas aeruginosa with lasI quorum-sensing deficiency during corneal infection.
Zhu H; Bandara R; Conibear TC; Thuruthyil SJ; Rice SA; Kjelleberg S; Givskov M; Willcox MD
Invest Ophthalmol Vis Sci; 2004 Jun; 45(6):1897-903. PubMed ID: 15161855
[TBL] [Abstract][Full Text] [Related]
7. Protease IV production in Pseudomonas aeruginosa from the lungs of adults with cystic fibrosis.
Smith L; Rose B; Tingpej P; Zhu H; Conibear T; Manos J; Bye P; Elkins M; Willcox M; Bell S; Wainwright C; Harbour C
J Med Microbiol; 2006 Dec; 55(Pt 12):1641-1644. PubMed ID: 17108265
[TBL] [Abstract][Full Text] [Related]
8. Epidemic population structure of Pseudomonas aeruginosa: evidence for a clone that is pathogenic to the eye and that has a distinct combination of virulence factors.
Lomholt JA; Poulsen K; Kilian M
Infect Immun; 2001 Oct; 69(10):6284-95. PubMed ID: 11553572
[TBL] [Abstract][Full Text] [Related]
9. Secretome of transmissible Pseudomonas aeruginosa AES-1R grown in a cystic fibrosis lung-like environment.
Scott NE; Hare NJ; White MY; Manos J; Cordwell SJ
J Proteome Res; 2013 Dec; 12(12):5357-69. PubMed ID: 23991618
[TBL] [Abstract][Full Text] [Related]
10. Analysis of quorum sensing-dependent virulence factor production and its relationship with antimicrobial susceptibility in Pseudomonas aeruginosa respiratory isolates.
Karatuna O; Yagci A
Clin Microbiol Infect; 2010 Dec; 16(12):1770-5. PubMed ID: 20132256
[TBL] [Abstract][Full Text] [Related]
11. Pseudomonas aeruginosa microevolution during cystic fibrosis lung infection establishes clones with adapted virulence.
Bragonzi A; Paroni M; Nonis A; Cramer N; Montanari S; Rejman J; Di Serio C; Döring G; Tümmler B
Am J Respir Crit Care Med; 2009 Jul; 180(2):138-45. PubMed ID: 19423715
[TBL] [Abstract][Full Text] [Related]
12. Pseudomonas aeruginosa strains from the chronically infected cystic fibrosis lung display increased invasiveness of A549 epithelial cells over time.
Harmer CJ; Triccas JA; Hu H; Rose B; Bye P; Elkins M; Manos J
Microb Pathog; 2012 Jul; 53(1):37-43. PubMed ID: 22516803
[TBL] [Abstract][Full Text] [Related]
13. Infections with Pseudomonas aeruginosa in patients with cystic fibrosis.
Tümmler B; Bosshammer J; Breitenstein S; Brockhausen I; Gudowius P; Herrmann C; Herrmann S; Heuer T; Kubesch P; Mekus F; Römling U; Schmidt KD; Spangenberg C; Walter S
Behring Inst Mitt; 1997 Feb; (98):249-55. PubMed ID: 9382747
[TBL] [Abstract][Full Text] [Related]
14. Pseudomonas aeruginosa diversity in distinct paediatric patient groups.
Tramper-Stranders GA; van der Ent CK; Wolfs TF; Kimpen JL; Fleer A; Johansen U; Johansen HK; Høiby N
Clin Microbiol Infect; 2008 Oct; 14(10):935-41. PubMed ID: 18752596
[TBL] [Abstract][Full Text] [Related]
15. Typing of Pseudomonas aeruginosa strains in Turkish cystic fibrosis patients.
Yagci A; Ciragil P; Over U; Sener B; Erturan Z; Soyletir G
New Microbiol; 2003 Jan; 26(1):109-14. PubMed ID: 12578318
[TBL] [Abstract][Full Text] [Related]
16. Genome diversity of Pseudomonas aeruginosa isolates from cystic fibrosis patients and the hospital environment.
Finnan S; Morrissey JP; O'Gara F; Boyd EF
J Clin Microbiol; 2004 Dec; 42(12):5783-92. PubMed ID: 15583313
[TBL] [Abstract][Full Text] [Related]
17. Great phenotypic and genetic variation among successive chronic Pseudomonas aeruginosa from a cystic fibrosis patient.
Lozano C; Azcona-Gutiérrez JM; Van Bambeke F; Sáenz Y
PLoS One; 2018; 13(9):e0204167. PubMed ID: 30212579
[TBL] [Abstract][Full Text] [Related]
18. Characterization of clonal strains of Pseudomonas aeruginosa isolated from cystic fibrosis patients in Ontario, Canada.
Beaudoin T; Aaron SD; Giesbrecht-Lewis T; Vandemheen K; Mah TF
Can J Microbiol; 2010 Jul; 56(7):548-57. PubMed ID: 20651854
[TBL] [Abstract][Full Text] [Related]
19. Characterization of Pseudomonas aeruginosa strains isolated from cystic fibrosis patients by different typing methods.
Hafiane A; Ravaoarinoro M
Pathol Biol (Paris); 2011 Oct; 59(5):e109-14. PubMed ID: 19896303
[TBL] [Abstract][Full Text] [Related]
20. Type III secretion phenotypes of Pseudomonas aeruginosa strains change during infection of individuals with cystic fibrosis.
Jain M; Ramirez D; Seshadri R; Cullina JF; Powers CA; Schulert GS; Bar-Meir M; Sullivan CL; McColley SA; Hauser AR
J Clin Microbiol; 2004 Nov; 42(11):5229-37. PubMed ID: 15528719
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
